WBC
PDLI

Westpac Banking Corp’s PDL BioPharma, Inc. PDLI Stock Holding History

Westpac Banking Corp’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-582,608
Closed -$4.49M – 994
2014
Q4 		$4.49M Hold
582,608
– – 0.04% 382
2014
Q3 		$4.35M Hold
582,608
– – 0.04% 365
2014
Q2 		$5.64M Sell
582,608
-134,300
-19% -$1.2M 0.05% 316
2014
Q1 		$5.96M Buy
716,908
+313,500
+78% +$2.69M 0.06% 281
2013
Q4 		$3.4M Buy
403,408
+142,000
+54% +$1.2M 0.04% 372
2013
Q3 		$2.08M Buy
261,408
+50,100
+24% +$403K 0.03% 440
2013
Q2 		$1.54M Buy
+211,308
New +$1.65M 0.02% 456

Other funds holding PDLI

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return